Revisiting Desensitization and Allergen Immunotherapy Concepts for the International Classification of Diseases (ICD)-11

Luciana Kase Tanno; Moises A Calderon; Nikolaos G Papadopoulos; Mario Sanchez-Borges; Lanny J Rosenwasser; Jean Bousquet; Ruby Pawankar; Juan Carlos Sisul; Alfonso Mario Cepeda; James Li; Antonella Muraro; Stanley Fineman; James L Sublett; Constance H Katelaris; Yoon-Seok Chang; Hee-Bom Moon; Thomas Casale; Pascal Demoly; Joint Allergy Academies

doi:10.1016/j.jaip.2015.12.022

Revisiting Desensitization and Allergen Immunotherapy Concepts for the International Classification of Diseases (ICD)-11

J Allergy Clin Immunol Pract. 2016 Jul-Aug;4(4):643-9. doi: 10.1016/j.jaip.2015.12.022. Epub 2016 Mar 8.

Authors

Luciana Kase Tanno¹, Moises A Calderon², Nikolaos G Papadopoulos³, Mario Sanchez-Borges⁴, Lanny J Rosenwasser⁵, Jean Bousquet⁶, Ruby Pawankar⁷, Juan Carlos Sisul⁸, Alfonso Mario Cepeda⁹, James Li¹⁰, Antonella Muraro¹¹, Stanley Fineman¹², James L Sublett¹³, Constance H Katelaris¹⁴, Yoon-Seok Chang¹⁵, Hee-Bom Moon¹⁶, Thomas Casale¹⁷, Pascal Demoly¹⁸; Joint Allergy Academies

Affiliations

¹ Hospital Sírio Libanês, São Paulo, Brazil; Division of Allergy, Department of Pulmonology, University Hospital of Montpellier, Montpellier, France; Pierre Louis Institute of Epidemiology and Public Health, Sorbonne Universités, Paris, France.
² Section of Allergy and Clinical Immunology, Imperial College London, National Heart and Lung Institute, Royal Brompton Hospital, London, United Kingdom.
³ Centre for Paediatrics and Child Health, Institute of Human Development, University of Manchester, Manchester, United Kingdom; Department of Allergy, 2nd Pediatric Clinic, University of Athens, Athens, Greece.
⁴ Allergy and Clinical Immunology Department, Centro Medico Docente La Trinidad, Caracas, Venezuela.
⁵ Division of Immunology Research, Department of Pediatrics, Children's Mercy Hospitals and Clinics, Kansas City, Mo.
⁶ Division of Allergy, Department of Pulmonology, University Hospital of Montpellier, Montpellier, France; Pierre Louis Institute of Epidemiology and Public Health, Sorbonne Universités, Paris, France.
⁷ Division of Allergy, Department of Pediatrics, Nippon Medical School, Tokyo, Japan.
⁸ American College of Allergy, Asthma and Immunology, Asunción, Paraguay.
⁹ Latin American Society of Allergy, Asthma and Immunology, Unidad Médica Portoazul, Corredor Universitario, Puerto Colombia, Colombia.
¹⁰ Division of Allergic Diseases, Mayo Clinic, Rochester, Minn.
¹¹ Department of Women and Child Health Padua General University Hospital, Padua, Italy.
¹² Department of Pediatrics, Emory University School of Medicine, Atlanta, Ga.
¹³ Section of Allergy and Immunology, Department of Pediatrics, University of Louisville School of Medicine, Louisville, Ky.
¹⁴ Department of Immunology and Allergy, Western Sydney University and Campbelltown Hospital, Sydney, NSW, Australia.
¹⁵ Division of Allergy and Clinical Immunology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Gyeonggi-do, Korea.
¹⁶ Department of Allergy and Clinical Immunology, Asan Medical Center, University of Ulsan, Seoul, Korea.
¹⁷ Morsani College of Medicine, University of South Florida, Tampa, Fla.
¹⁸ Division of Allergy, Department of Pulmonology, University Hospital of Montpellier, Montpellier, France; Pierre Louis Institute of Epidemiology and Public Health, Sorbonne Universités, Paris, France. Electronic address: [email protected].

PMID: 26969269
DOI: 10.1016/j.jaip.2015.12.022

Abstract

Allergy and hypersensitivity intervention management procedures, such as desensitization and/or tolerance induction and immunotherapy, have not been pondered up to now in the content of International Classification of Diseases (ICD) context because the focus has been on prioritizing the condition implementations. Tremendous efforts have been devoted to implementing allergic and hypersensitivity conditions in the forthcoming ICD-11. However, we consider that it is crucial now to have nomenclature and classification universally accepted for these procedures to be able to provide scientifically consistent proposals into the new ICD-11 platform for the best practice parameters of our specialty. With the aim of promoting a harmonized comprehension and aligning it with the ICD-11 revision, we have reviewed the definitions and concepts currently used for desensitization and/or tolerance induction and immunotherapy. We strongly believe that this review is a key instrument to support the allergy specialty identity into the ICD-11 framework and serves as a platform to perform positive quality improvement in clinical practice.

Keywords: Allergy; Desensitization; Immunotherapy; International Classification of Diseases (ICD); World Health Organization (WHO).

Publication types

Review
Research Support, Non-U.S. Gov't

MeSH terms

Desensitization, Immunologic*
Humans
International Classification of Diseases